In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Qinglan Bao; Xiaoxiao Zhang; Yingsong Chen; Tegexibaiyin Wang; Bateer Siqin

doi:10.3791/66810

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

JoVE Journal
Biology

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Biology

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Full Text

1,935 Views

07:03 min

July 19, 2024

DOI: 10.3791/66810-v

Qinglan Bao¹, Xiaoxiao Zhang², Yingsong Chen*^1,3,4, Tegexibaiyin Wang*⁵, Bateer Siqin*⁶

¹Inner Mongolia Medical University, ²Xilin Gol League Mongolian Medical Hospital, ³National and local Joint Mongolian Medicine R & D Engineering Center, ⁴Inner Mongolia Minzu University, ⁵Affiliated Hospital of Inner Mongolia Minzu University, ⁶Traditional Chinese & Mongolian Medical Research Institute of Inner Mongolia

Overview

This study investigates the use of oleic acid-induced HepG2 cells as a model for metabolic dysfunction-associated steatotic liver disease. By analyzing the effects of oleic acid on these cells, the research aims to elucidate the mechanisms underlying this liver condition.

Key Study Components

Research Area

Metabolic dysfunction-associated steatotic liver disease
Effect of oleic acid on liver cells
Traditional Mongolian medicine therapy

Background

Importance of studying metabolic liver diseases
Use of HepG2 cells as a model system
Previous findings on fatty liver disease mechanisms

Methods Used

Cell culture and treatment with oleic acid
Assessment of lipid content via Oil Red O staining and triglyceride measurements
Optical density measurements using a microplate reader

Main Results

Oleic acid treatment decreased cell survival rates at higher concentrations
Significant increase in lipid droplet formation in treated HepG2 cells
Elevated total triglycerides in cell supernatants post-treatment

Conclusions

The study successfully establishes a cell model for investigating steatotic liver disease.
Findings highlight the impact of oleic acid on lipid accumulation in liver cells, informing future therapeutic strategies.

Frequently Asked Questions

What is the significance of studying HepG2 cells?

HepG2 cells are a widely used human liver cell line that serves as an important model for studying liver-related metabolic diseases.

How does oleic acid affect HepG2 cells?

Oleic acid treatment leads to increased lipid droplet formation and reduced cell viability at higher concentrations.

What methods were used to assess lipid content?

Lipid content was measured using Oil Red O staining and total triglyceride assays, with optical density readings taken with a microplate reader.

What future studies are planned?

Future studies aim to explore the mechanisms of action of various therapies on the established cell model.

How can this study inform traditional medicine?

Insights from this research may enhance the understanding of traditional Mongolian medicine’s role in treating liver diseases.

What were the main findings of the study?

The study found that oleic acid promotes lipid accumulation in HepG2 cells, indicating potential pathways for metabolic disease interventions.

This article describes the use of oleic acid-induced HepG2 cells as a model for metabolic dysfunction-associated steatotic liver disease.

Our research direction is the study of traditional Mongolian medicine. By establishing a metabolic dysfunction associated steatotic liver disease cell model, the role and the mechanism of common therapy are studied. The findings of the presence study will improve advantages in the future and enabling the establishment of metabolic dysfunction associated steatotic liver disease cell models, and the investigation of the disease underlying mechanisms.

A future study will be conducted based on the metabolic dysfunction associated steatotic liver disease cell model to investigate the mechanism of action of lead lowering effect of Crohn's. To begin, seed overnight grown culture of HepG2 in 100 microliters of DMEM in each well of a 96-well plate. Incubate the cells at 37 degrees Celsius and 5%carbon dioxide for 24 hours.

View the full transcript and gain access to thousands of scientific videos